151 related articles for article (PubMed ID: 37006037)
1. Progress in the knowledge on the transformation of lung adenocarcinoma to small-cell lung cancer.
Wang A; Han C; Zhao H; Zheng Z; Ye X; Shan R
J Cancer Res Ther; 2023 Feb; 19(1):14-19. PubMed ID: 37006037
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer.
Lin MW; Su KY; Su TJ; Chang CC; Lin JW; Lee YH; Yu SL; Chen JS; Hsieh MS
Lung Cancer; 2018 Nov; 125():282-290. PubMed ID: 30429033
[TBL] [Abstract][Full Text] [Related]
3. Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?
Sehgal K; Varkaris A; Viray H; VanderLaan PA; Rangachari D; Costa DB
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581048
[TBL] [Abstract][Full Text] [Related]
4. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.
Oser MG; Niederst MJ; Sequist LV; Engelman JA
Lancet Oncol; 2015 Apr; 16(4):e165-72. PubMed ID: 25846096
[TBL] [Abstract][Full Text] [Related]
5. Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis.
Roca E; Gurizzan C; Amoroso V; Vermi W; Ferrari V; Berruti A
Cancer Treat Rev; 2017 Sep; 59():117-122. PubMed ID: 28806542
[TBL] [Abstract][Full Text] [Related]
6. Histological transformation into SCLC: An important resistance mechanism of NSCLC upon immunotherapy.
Zeng J; Ding X; Ding J; Wang X
Front Immunol; 2023; 14():1275957. PubMed ID: 38022621
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of treatment modes and clinical outcomes of small cell lung cancer transformed from epidermal growth factor receptor mutant lung adenocarcinoma.
Wang S; Xie T; Hao X; Wang Y; Hu X; Wang L; Li Y; Li J; Xing P
Thorac Cancer; 2021 Oct; 12(19):2585-2593. PubMed ID: 34490724
[TBL] [Abstract][Full Text] [Related]
8. Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study.
Wang W; Xu C; Chen H; Jia J; Wang L; Feng H; Wang H; Song Z; Yang N; Zhang Y
Lung Cancer; 2021 May; 155():20-27. PubMed ID: 33714778
[TBL] [Abstract][Full Text] [Related]
9. An EGFR-mutant lung adenocarcinoma that transformed into small-cell lung cancer. A case report.
Chowaniecova G; Berzinec P; Kosturiakova G; Plank L; Farkasova A; Sekeresova M; Juskanic D; Ondrus D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Dec; 166(4):451-454. PubMed ID: 36036563
[TBL] [Abstract][Full Text] [Related]
10. Sequential occurrence of small cell and non-small lung cancer in a male patient: Is it a transformation?
Wahab A; Kesari K; Chaudhary S; Khan M; Khan H; Smith S; Boumber Y
Cancer Biol Ther; 2017 Dec; 18(12):940-943. PubMed ID: 29157085
[TBL] [Abstract][Full Text] [Related]
11. Transformation to small-cell lung cancer following treatment with EGFR tyrosine kinase inhibitors in a patient with lung adenocarcinoma.
Watanabe S; Sone T; Matsui T; Yamamura K; Tani M; Okazaki A; Kurokawa K; Tambo Y; Takato H; Ohkura N; Waseda Y; Katayama N; Kasahara K
Lung Cancer; 2013 Nov; 82(2):370-2. PubMed ID: 24012411
[TBL] [Abstract][Full Text] [Related]
12. [Research Advances on Transformation to Small Cell Lung Cancer].
Zhang S; Li S; Cui Y; Cheng Y
Zhongguo Fei Ai Za Zhi; 2021 Oct; 24(10):729-733. PubMed ID: 34696545
[TBL] [Abstract][Full Text] [Related]
13. Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer.
Bar J; Ofek E; Barshack I; Gottfried T; Zadok O; Kamer I; Urban D; Perelman M; Onn A
Lung Cancer; 2019 Dec; 138():109-115. PubMed ID: 31683093
[TBL] [Abstract][Full Text] [Related]
14. Non-small cell lung cancer transdifferentiation into small cell lung cancer: A case series.
Ahmed T; Vial MR; Ost D; Stewart J; Hasan MA; Grosu HB
Lung Cancer; 2018 Aug; 122():220-223. PubMed ID: 30032836
[TBL] [Abstract][Full Text] [Related]
15. Small cell lung cancer transformation from EGFR-mutated lung adenocarcinoma: A case report and literatures review.
Liu Y
Cancer Biol Ther; 2018 Jun; 19(6):445-449. PubMed ID: 29461911
[TBL] [Abstract][Full Text] [Related]
16. Transformation of lung adenocarcinoma to small cell lung carcinoma in the setting of tyrosine kinase inhibitor therapy: Cytological approach of a clinically challenging phenomenon.
El Hussein S; Khader SN
Diagn Cytopathol; 2019 Aug; 47(8):845-850. PubMed ID: 31017747
[TBL] [Abstract][Full Text] [Related]
17. The landscape of immune checkpoint inhibitor therapy in advanced lung cancer.
Wang C; Li J; Zhang Q; Wu J; Xiao Y; Song L; Gong H; Li Y
BMC Cancer; 2021 Aug; 21(1):968. PubMed ID: 34454455
[TBL] [Abstract][Full Text] [Related]
18. Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas.
Lee JK; Lee J; Kim S; Kim S; Youk J; Park S; An Y; Keam B; Kim DW; Heo DS; Kim YT; Kim JS; Kim SH; Lee JS; Lee SH; Park K; Ku JL; Jeon YK; Chung DH; Park PJ; Kim J; Kim TM; Ju YS
J Clin Oncol; 2017 Sep; 35(26):3065-3074. PubMed ID: 28498782
[TBL] [Abstract][Full Text] [Related]
19. Small-Cell Lung Cancer Transformation as a Mechanism of Resistance to Pralsetinib in RET-Rearranged Lung Adenocarcinoma: A Case Report.
Gazeu A; Aubert M; Pissaloux D; Lantuejoul S; Pérol M; Ikhlef N; Bouhamama A; Franceschi T; Swalduz A
Clin Lung Cancer; 2023 Jan; 24(1):72-75. PubMed ID: 36437214
[TBL] [Abstract][Full Text] [Related]
20. RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer.
Niederst MJ; Sequist LV; Poirier JT; Mermel CH; Lockerman EL; Garcia AR; Katayama R; Costa C; Ross KN; Moran T; Howe E; Fulton LE; Mulvey HE; Bernardo LA; Mohamoud F; Miyoshi N; VanderLaan PA; Costa DB; Jänne PA; Borger DR; Ramaswamy S; Shioda T; Iafrate AJ; Getz G; Rudin CM; Mino-Kenudson M; Engelman JA
Nat Commun; 2015 Mar; 6():6377. PubMed ID: 25758528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
